TELMI-H Tablet
Combination Therapy for Hypertension and Heart Protection
Composition
Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg
- Pack: 10 x 10 Tablets
- Prescription medicine
- Available to order
Overview
TELMI - H combines Telmisartan, an angiotensin II receptor blocker (ARB), with Hydrochlorothiazide, a thiazide diuretic, to provide a dual mechanism for effectively controlling high blood pressure (hypertension). This combination helps relax blood vessels and reduce excess fluid in the body, lowering blood pressure and reducing the risk of cardiovascular complications.
Key Benefits
- Dual Action: Telmisartan lowers blood pressure by blocking the effects of angiotensin II, while Hydrochlorothiazide helps eliminate excess salt and fluid from the body
- Effective Hypertension Control: A potent combination that enhances blood pressure reduction, making it suitable for patients who require multiple mechanisms to manage hypertension
- Heart Protection: Reduces the risk of stroke, heart attack, and kidney damage in patients with high blood pressure
- Convenient Treatment: Once-daily dosing for improved patient compliance
Indications
- Hypertension (High Blood Pressure): Management of high blood pressure, particularly for patients not adequately controlled on monotherapy
- Heart Failure and Related Complications: Adjunct treatment to improve cardiovascular function and reduce the risk of heart-related complications
- Prevention of Stroke and Kidney Damage: Reduces the risk of heart attack, stroke, and kidney failure in patients with cardiovascular disease or diabetes
